An analysis of the phase 3 ARASENS study revealed new information on prostate-specific antigen (PSA) responses and their association with outcomes. The study, led by Fred Saad, MD, FRCS, and colleagues, analyzed the efficacy of darolutamide in combination with androgen deprivation therapy (ADT) and docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). ...
Prostate Cancer
Advertisement
Latest News
A CR was observed in the first patient with mCRPC to receive 2 cycles of 67Cu-SAR-bisPSMA at a dosage of 8GBq.
Dr. Vandekerkhove explains her research on genomic testing in prostate cancer.
The benefits of PSA screening alone are offset by excess negative biopsies and the over-detection of low-grade cancers.
The study sought to determine the outcomes and prevalence related to somatic or germline HRR alterations.
Researchers performed a post hoc analysis on patient data from the randomized, phase 3 LATITUDE trial.
Dr. Spratt ponders the evolving integration of RT with systemic treatments, challenges in counseling patients, and more.
Advertisement
Conference Coverage
Dr. Miles-Thomas shares the challenges of female urology and her vision for her tenure as AUA treasurer.
Dr. Afari elaborates on the factors he identified that contribute to renal function improvement post-partial nephrectomy.
Dr. Galsky shares the first OS data update on the CheckMate 274 trial, which he gave at the 2024 EAU Congress.
Dr. Julian Chavarriaga describes his study on using miRNA as a liquid biomarker to detect malignancy in testicular masses.
Dr. Finati discusses what the future has in store for further investigation utilizing larger patient databases.
Drs. Grasso and Verhovsky discuss the potential of endoscopic treatment with surveillance for patients with bladder cancer.
Advertisement
Advertisement
Latest News
Patients underwent treatment with lenvatinib plus everolimus as a second-line therapy.
A review analyzed 30 meta-analyses to determine the association between pretreatment NLR and immunotherapy outcomes.
Dr. Miles-Thomas shares the challenges of female urology and her vision for her tenure as AUA treasurer.
